- Glenn Hearson
Study to assess remote monitoring of patients with an interstitial lung disease
Updated: Sep 5, 2022
We will be shortly commencing a new study to find out if it is practical for patients with a fibrotic lung disease, to take their own spirometry (breathing test) and pulse oximetry (to estimate oxygen in your blood) readings at home every day.
Remote monitoring of interstitial lung disease to provide continuity of care and shielding from risks associated with in-clinic assessment
The study is funded by an Innovate UK grant: Care Transformation in Respiratory Disease.
We are working in collaboration with the study sponsors, patientMpower and Quiddity Health along with Imperial College London.
Dr Gauri Saini from the NIHR Nottingham Biomedical Research Centre is our local Principal Investigator. The study lead is Lucy Howard also from the NIHR Nottingham Biomedical Research Centre.
What is the Purpose of the study?
We to assess the feasibility of assessing lung health remotely.
We are trying to find out if it is practical for patients like yourself, with a fibrotic lung disease, to take their own spirometry (breathing test) and pulse oximetry (to estimate oxygen in your blood) readings at home every day. We are trying to assess if this approach could be useful for remote monitoring of health in patients with long-term lung conditions.
What will happen in the study?
Participants will be provided with a small hand-held spirometer to blow into (to measure breathing tests) and will also be provided with a small pulse oximeter. When this is placed on your finger tip, it can estimate the amount of oxygen in your blood. These devices connect with a smartphone application ‘app’ (called “patientMpower app”) which will download the breathing test and oxygen information onto your smartphone.
We would like you to use the home spirometer and the pulse oximeter every day for three months.
This study has now fully completed